Check out James Pickering 's 2024 eyecare outlooks & predictions 👀 Industry Perspectives: Looking...
𝐍𝐎𝐕𝐄𝐌𝐁𝐄𝐑 𝐍𝐄𝐖𝐒 𝐑𝐎𝐔𝐍𝐃 𝐔𝐏 𝐈𝐒 𝐇𝐄𝐑𝐄! 🙌
👓Business Merger Announcement: Thélios to Acquire Barton Perreira
Thélios recently announced an agreement to acquire Barton Perreira, a reowned luxury eyewear company. This strategic move is set to build upon the already successful track record of both companies, elevating them to new heights in the eyewear industry. The partnership signifies a fusion of strengths, where Thélios and Barton Perreira will collaborate to enhance their respective position in the market.
In a statement, Thélios CEO Alessandro Zanardo stated: “We are looking forward to working with Barton Perreira’s talented team and dedicate ourselves to preserving its unique identity while leveraging our resources and expertise to further develop the brand”.
👁️🗨️Visionix partners with 20/20Now on tele-optometry
Visionix USA has entered into a strategic alliance with 20/20NOW to introduce affordable ocular telemedicine and tele-optometry comprehensive eye exams to patients across the US. In this collaboration, Visionix will integrate 20/20NOWs cutting-edge tele-optometry platform with its own integrated devices to provide tele-optometry services. Customers will now have expanded opportunities to explore an alternative business model that features telehealth professionals. These connections could allow eyecare professionals to launch multi-location opticals and practises, incorporating tele-optometry into their service offerings.
😮Octurx launches OcuLenz AR headset for advanced macular degeneration.
Ocutrx Technologies, Inc. has officially introduced the OcuLenz augmented/extended reality (AR/XR) headset, specifically engineered for patients with advanced macular degeneration. The lightweight headset operates by incorporating high-contrast, pixel-manipulated images and real-world video imagery onto the user’s remaining viable field of view. The device offers an immersive visual experience tailored to the user’s remaining visual field and is marketed as providing fast visual field testing with immediate results via a digital feed, which could allow for virtual vision monitoring by an eyecare professional.
👀First AI-based medical software solution approved
RetInSight’s GA Monitor is the first AI-based medical software solution to receive approval as a Class II medical device under the EU Medical Device Regulation, opening doors for routine clinical application. The GA Monitor, designed for the comprehensive management of GA using optical coherence tomography, introduces the ability to visualise and measure the condition of photoreceptors. CEO of RetInSight, Corinna zur Bonsen says, “With the launch of our GA Monitor, we are supporting ophthalmologists in clinical decisions by offering reliable software based on medical findings.”